Preemptive treatment with therapeutic plasma exchange and rituximab for early donor-specific antibodies after lung transplantation

Journal of Heart and Lung Transplantation

Volumn 34, Issue 1, 2016, Pages 50-58

  Ius, Fabio ^a   Sommer, Wiebke ^a   Tudorache, Igor ^a   Kühn, Christian ^a   Avsar, Murat ^a   Siemeni, Thierry ^a   Salman, Jawad ^a   Hallensleben, Michael ^b   Kieneke, Daniela ^b   Greer, Mark ^c   Gottlieb, Jens ^c   Kielstein, Jan T ^d   Boethig, Dietmar ^a   Welte, Tobias ^c   Haverich, Axel ^a   Warnecke, Gregor ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Transfusion Medicine   (Germany)

^c Respiratory Medicine   (Germany)

^d Hypertension and Nephrology ^*  (Germany)

Author keywords

death; donor specific antibodies; human leukocyte antigen; lung transplant; preemptive treatment; therapeutic plasma exchange

Indexed keywords

HLA ANTIBODY; RITUXIMAB; ANTIBODY; CD20 ANTIGEN; HLA ANTIGEN; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BRONCHIOLITIS OBLITERANS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INFECTION; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PLASMAPHERESIS; SINGLE DRUG DOSE; STEROID THERAPY; DONOR; GERMANY; GRAFT REJECTION; IMMUNOLOGY; INCIDENCE; MIDDLE AGED; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; SURVIVAL RATE; TRENDS;

ADULT; ANTIBODIES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, CD20; FEMALE; GERMANY; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOLOGIC FACTORS; INCIDENCE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PLASMA EXCHANGE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE DONORS;

EID: 84919967844     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2014.09.019     Document Type: Article

References (36)

1. D. Hadjiliadis, C. Chaparro, and N.L. Reinsmoen Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study J Heart Lung Transplant 24 2005 S249 S254
2. T. Martinu, D.N. Howell, and S.M. Palmer Acute cellular rejection and humoral sensitization in lung transplant recipients Semin Respir Crit Care Med 31 2010 179 188
3. A.S. Shah, L. Nwakanma, and C. Simpkins Pretransplant panel reactive antibodies in human lung transplantation: an analysis of over 10,000 patients Ann Thorac Surg 85 2008 1919 1924
4. A.A. Mangi, D.P. Mason, and E.R. Nowicki Predictors of acute rejection after lung transplantation Ann Thorac Surg 91 2011 1754 1762
5. W. McManigle, E.N. Pavlisko, and T. Martinu Acute cellular and antibody-mediated allograft rejection Semin Respir Crit Care Med 34 2013 320 335
6. L.D. Snyder, Z. Wang, and D.F. Chen Implications for human leukocyte antigen antibodies after lung transplantation: a 10 year experience in 441 patients Chest 144 2013 226 233
7. O. Brugiere, C. Suberbielle, and G. Thabut Lung transplantation in patients with pretransplantation donor-specific antibodies detected by Luminex assay Transplantation 95 2013 761 765
8. L.J. Lobo, R.M. Aris, and J. Schmitz Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation J Heart Lung Transplant 32 2013 70 77
9. C.A. Witt, J.P. Gaut, and R.D. Yusen Acute antibody-mediated rejection after lung transplantation J Heart Lung Transplant 32 2013 1034 1040
10. F. Ius, W. Sommer, and I. Tudorache Early donor-specific antibodies in lung transplantation: risk factors and impact on survival J Heart Lung Transplant 33 2014 1255 1263
11. P. Campbell Clinical relevance of human leukocyte antigen antibodies in liver, heart, lung and intestine transplantation Curr Opin Organ Transplant 18 2013 463 469
12. A.A. Zachary, R.A. Montgomery, and L.E. Ratner Specific and durable elimination of antibody to donor HLA antigens in renal-transplant patients Transplantation 76 2003 1519 1525
13. N. Singh, J. Pirsch, and M. Samaniego Antibody-mediated rejection: treatment alternatives and outcomes Transplant Rev 23 2009 34 46
14. T. Fehr, and A. Gaspert antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale Transpl Int 25 2012 623 632
15. A. Nishio-Lucar, R.A. Balogun, and S. Sanoff Therapeutic apheresis in kidney transplantation: a review of renal transplant immunobiology and current interventions with apheresis medicine J Clin Apher 28 2013 56 63
16. R.R. Hachem, R.D. Yusen, and B.F. Meyers Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation J Heart Lung Transplant 29 2010 973 980
17. A.H. Daoud, and A.D. Betensley Diagnosis and treatment of antibody mediated rejection in lung transplantation: a retrospective case series Transpl Immunol 28 2013 1 5
18. R. Jackups, C. Canter, and S.C. Sweet Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection J Clin Apher 28 2013 301 308
19. F. Ius, C. Kuehn, and I. Tudorache Lung transplantation on cardiopulmonary support: venoarterial extracorporeal membrane oxygenation outperformed cardiopulmonary bypass J Thorac Cardiovasc Surg 144 2012 1510 1516
20. M. Estenne, J. Maurer, and A. Boehler Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria J Heart Lung Transplant 21 2002 27 310
21. J.C. Lee, J.D. Christie, and S. Keshavjee Primary graft dysfunction: definition, risk factors, short- and long-term outcomes Semin Respir Crit Care Med 31 2010 161 171
22. J.B. Imboden The immunopathogenesis of rheumatoid arthritis Annu Rev Pathol 4 2009 417 434
23. N. Angaswamy, V. Tiriveedhi, and N.J. Sarma Interplay between immune responses to HLA and non-HLA self-antigens in allograft rejection Hum Immunol 74 2013 1478 1485
24. J.J. Solomon, and A. Fischer Connective tissue disease-associated interstitial lung disease: a focused review J Intensive Care Med 2013 10.1177/0885066613516579 [Epub ahead of print]
25. S. Stewart, M.C. Fishbein, and G.I. Snell Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection J Heart Lung Transplant 26 2007 1229 1242
26. G. Berry, M. Burke, and C. Andersen Pathology of pulmonary antibody-mediated rejection: 2012 update from the Pathology Council of the ISHLT J Heart Lung Transplant 32 2013 14 21
27. N. Lachmann, K. Todorova, and H. Schulze Luminex and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion Transfus Med Hemother 40 2013 182 189
28. B.D. Tait, C. Süsal, and H.M. Gebel Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation Transplantation 95 2013 19 47
29. E.H. Blackstone Comparing apples and oranges J Thorac Cardiovasc Surg 123 2002 8 15
30. R.D. Yusen, J.D. Christie, and L.B. Edwards The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report-2013; focus theme: age J Heart Lung Transplant 32 2014 965 978
31. Y.T. Becker, M. Samaniego-Picota, and H.W. Sollinger The emerging role of rituximab in organ transplantation Transpl Int 19 2006 621 628
32. V. Zarkhin, L. Li, and N. Kambham A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation Am J Transplant 8 2008 2607 2617
33. M.R. Clatworthy Targeting B cells and antibody in transplantation Am J Transplant 11 2011 1359 1367
34. L.J. Lobo, J.M. Reynolds, and L.D. Snyder Rituximab-associated progressive multifocal leukoencephalopathy after lung transplantation J Heart Lung Transplant 32 2013 752 753
35. N. Mehra, J. Siddiqui, and A. Baranwal Clinical relevance of antibody development in renal transplantation Ann N Y Acad Sci 1283 2013 30 42
36. S.K. Takemoto, A. Zeevi, and S. Feng National conference to assess antibody-mediated rejection in solid organ transplantation Am J Transplant 4 2004 1033 1041